Marianne E Pavel Selected Research

Hypercholesterolemia

1/2021

Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marianne E Pavel Research Topics

Disease

17	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2005
10	Neoplasms (Cancer) 01/2021 - 01/2005
6	Carcinoid Tumor (Carcinoid) 01/2019 - 12/2011
5	Disease Progression 12/2021 - 02/2011
5	Fatigue 01/2021 - 02/2011
4	Stomatitis 01/2017 - 02/2011
3	Neuroendocrine Carcinoma 01/2021 - 04/2005
3	Diarrhea 01/2017 - 02/2011
2	Hyperglycemia 01/2021 - 02/2011
2	Infections 03/2016 - 02/2011
2	Exanthema (Rash) 12/2011 - 02/2011
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021
1	Hypercholesterolemia 01/2021
1	Nausea 01/2021
1	Adenocarcinoma 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2017
1	Flushing 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Astrocytoma (Pilocytic Astrocytoma) 01/2013
1	Tuberous Sclerosis (Bourneville's Disease) 01/2013
1	Carcinogenesis 01/2013
1	Angiomyolipoma 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 12/2012
1	Anemia 02/2011
1	Chronic Hepatitis C 01/2006
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2003
1	Acidosis 01/2003
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2003
1	Asphyxia (Suffocation) 01/2003

Drug/Important Bio-Agent (IBA)

10	Everolimus FDA Link 01/2021 - 02/2011
6	Pharmaceutical PreparationsIBA 01/2021 - 02/2011
5	Octreotide (Sandostatin)FDA LinkGeneric 12/2021 - 01/2006
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 01/2005
3	TOR Serine-Threonine KinasesIBA 01/2021 - 02/2011
3	lanreotide (Somatuline)FDA Link 01/2019 - 08/2018
3	Chromogranin AIBA 01/2019 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2018
3	Hydroxyindoleacetic AcidIBA 01/2019 - 01/2005
2	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2021 - 01/2017
2	PlatinumIBA 01/2021 - 05/2020
2	AcidsIBA 01/2019 - 08/2018
2	Interferon-alpha (Interferon Alfa)IBA 01/2006 - 01/2005
1	lutetium Lu 177 dotatateIBA 12/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	spartalizumabIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Proton Pump InhibitorsIBA 08/2018
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2017
1	GastrinsIBA 01/2017
1	Glucagon (Glukagon)FDA Link 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Protein Kinases (Protein Kinase)IBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2006
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2005
1	Interleukin-8 (Interleukin 8)IBA 04/2005
1	CytokinesIBA 04/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2005
1	angiogeninIBA 04/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2005
1	Streptozocin (Streptozotocin)FDA Link 01/2005
1	SaltsIBA 01/2003

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2005
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2005
1	Adjuvant Chemotherapy 05/2020
1	Radiotherapy 01/2017
1	Precision Medicine 11/2016
1	Prostheses and Implants (Prosthesis) 12/2012
1	Stents 12/2012
1	Biological Therapy 01/2005
1	Artificial Respiration (Mechanical Ventilation) 01/2003